TaoWeave, Inc DEFA14A, filed Nov 8, 2023
TaoWeave, Inc. (TWAV)
DEFA14A
2023-11-08
View Original
Added on
October 18, 2026
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934
(Amendment No. )
(Amendment No. )
Filed by the Registrant | [X] | ||||||||||||||||
Filed by a party other than the Registrant | [ ] | ||||||||||||||||
Check the appropriate box: | |||||||||||||||||
[ ] | Preliminary Proxy Statement | ||||||||||||||||
[ ] | Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) | ||||||||||||||||
[ ] | Definitive Proxy Statement | ||||||||||||||||
[X] | Definitive Additional Materials | ||||||||||||||||
[ ] | Soliciting Material under § 240.14a-12 | ||||||||||||||||
OBLONG, INC.
(Name of Registrant as Specified In Its Charter)
(Name of Registrant as Specified In Its Charter)
N/A
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] | No fee required. | ||||||||||
[ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. | ||||||||||
| (1) | Title of each class of securities to which transaction applies: | ||||||||||
| (2) | Aggregate number of securities to which transaction applies: | ||||||||||
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): | ||||||||||
| (4) | Proposed maximum aggregate value of transaction: | ||||||||||
| (5) | Total fee paid: | ||||||||||
[ ] | Fee paid previously with preliminary materials: | ||||||||||
[ ] | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. | ||||||||||
| (1) | Amount Previously Paid: | ||||||||||
| (2) | Form, Schedule or Registration Statement No.: | ||||||||||
| (3) | Filing Party: | ||||||||||
| (4) | Date Filed: | ||||||||||
OBLONG, INC.
| 25587 Conifer Road, Suite 105-231, | ||
| Conifer, Colorado 80433 | ||
SUPPLEMENT TO PROXY STATEMENT
FOR THE ANNUAL MEETING OF STOCKHOLDERS
TO BE HELD DECEMBER 4, 2023
This supplement (the “Supplement”) amends and supplements the definitive proxy statement on Schedule 14A (the “Proxy Statement”) filed by Oblong, Inc. (the “Company”) with the Securities and Exchange Commission on October 30, 2023 in connection with the Company’s 2023 Annual Meeting of Stockholders (the “Annual Meeting”), to be held at 11:30 A.M. MST on December 4, 2023.
The purpose of this Supplement is to correct the Proxy Statement regarding the number of shares issued and outstanding as of the Record Date. The corrections to the existing disclosure in the Proxy Statement are set forth below under the heading “Corrections to the Proxy Statement.” Other than these corrections, the Proxy Statement remains unchanged, and this Supplement does not otherwise amend, supplement, or affect the Proxy Statement. From and after the date of this Supplement, any references to the “Proxy Statement” are to the Proxy Statement as amended and supplemented by this Supplement. This Supplement should be read in conjunction with the Proxy Statement and the other proxy materials previously made available to stockholders in connection with the Annual Meeting.
If you have already voted your shares, you do not need to vote again unless you would like to change or revoke your prior vote on any proposal. Refer to the disclosure in the Proxy Statement under “Questions and Answers about the Oblong Annual Meeting—How can I change my vote after I return my proxy card?” for instructions on how to do so.
Corrections to the Proxy Statement
All prior references to 15,002,416 shares of Common Stock issued and outstanding as of the Record Date on pages 2, 6, and 32 shall be deleted and instead refer to 14,947,922 shares of Common Stock issued and outstanding as of the Record Date.
In addition, the table on page 26 describing the effect of a reverse stock split in different ratios based on (i) the number of shares of Common Stock issued and outstanding and (ii) the number of shares of Common Stock reserved for issuance pursuant to outstanding warrants, preferred stock, options, and restricted stock units and under our equity incentive plan, each as of the Record Date, shall be deleted and replaced with the table below:
| Number of Shares Before Reverse Stock Split | Reverse Stock Split Ratio of 1-for-10 | Reverse Stock Split Ratio of 1-for-20 | Reverse Stock Split Ratio of 1-for-45 | |||||||||||||||||||||||
| Number of Shares of Common Stock Issued and Outstanding | 14,947,922 | 1,494,793 | 747,397 | 332,177 | ||||||||||||||||||||||
| Number of Shares of Common Stock Reserved for Issuance | 130,386,496 | 13,038,650 | 6,519,325 | 2,897,478 | ||||||||||||||||||||||